| dc.contributor.author | Streinu, A. | |
| dc.contributor.author | Brouwer, W. P. | |
| dc.contributor.author | Xie, Q. | |
| dc.contributor.author | Sonneveld, M. J. | |
| dc.contributor.author | Zhang, N. P. | |
| dc.contributor.author | Zhang, Q. | |
| dc.contributor.author | Mazur, W. | |
| dc.contributor.author | Reijnders, J. G. P. | |
| dc.contributor.author | Verhey, E. | |
| dc.contributor.author | Hansen, B. E. | |
| dc.contributor.author | Janssen, H. L. A. | |
| dc.contributor.author | Tabak, F. | |
| dc.contributor.author | Wang, J. -Y. | |
| dc.contributor.author | Idilman, R. | |
| dc.contributor.author | Reesink, H. W. | |
| dc.contributor.author | Diculescu, M. | |
| dc.contributor.author | Simon, K. | |
| dc.contributor.author | Voiculescu, M. | |
| dc.contributor.author | Akdogan, M. | |
| dc.date.accessioned | 2021-03-03T08:59:33Z | |
| dc.date.available | 2021-03-03T08:59:33Z | |
| dc.identifier.citation | Brouwer W. P. , Xie Q., Sonneveld M. J. , Zhang N. P. , Zhang Q., Tabak F., Streinu A., Wang J. -. , Idilman R., Reesink H. W. , et al., "ADDING PEGINTERFERON TO ENTECAVIR INCREASES RESPONSE RATES IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS: WEEK 96 RESULTS OF A GLOBAL MULTICENTER RANDOMISED TRIAL (ARES STUDY)", 49th Annual International Liver Congress of the European-Association-for-the-Study-of-the-Liver, London, Kanada, 9 - 13 Nisan 2014, cilt.60 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_1a99c288-07c4-4d68-a7e3-2ab7392d91cc | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/23169 | |
| dc.identifier.uri | https://doi.org/10.1016/s0168-8278(14)60005-2 | |
| dc.language.iso | eng | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Tıp | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Gastroenteroloji-(Hepatoloji) | |
| dc.subject | GASTROENTEROLOJİ VE HEPATOLOJİ | |
| dc.subject | Klinik Tıp | |
| dc.title | ADDING PEGINTERFERON TO ENTECAVIR INCREASES RESPONSE RATES IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS: WEEK 96 RESULTS OF A GLOBAL MULTICENTER RANDOMISED TRIAL (ARES STUDY) | |
| dc.type | Bildiri | |
| dc.contributor.department | Erasmus University Rotterdam , , | |
| dc.identifier.volume | 60 | |
| dc.contributor.firstauthorID | 143837 | |